On April 17, Georgia Bio released initial findings from our 2019 State of the Life Sciences Industry Report. The top finding: the industry demonstrated a 14.9 percent growth in the past decade. That rate is nearly double the national average.

Following a presentation by Georgia Bio President & CEO Maria Thacker-Goethe, ATDC’s John Olsen moderated a conversation with GRA President & CEO Russell Allen and U.S. Head of Government Relations for UCB Joe Zorzoli and Lt. Governor Geoff Duncan. Afterwards, the Lt. Governor shared his thoughts on the topic, learnings from his first legislative session in office and policy priorities with Write2Market VP of Healthcare Paul Snyder.

“The best thing we can do here in Georgia is create an ecosystem that continues to allow for a growing economy, a talented workforce and significant potential in front of it,” he says.

 

We would like to thank Lt. Governor Duncan for his time and support, as well as all who attended the quarterly meeting. Please mark your calendars for the next Georgia Bio Quarterly Member Meeting set for June 20th at 7:30 a.m. back at Upstairs Atlanta. The topic: Innovation in Drug Development. Stay tuned for more.

About Georgia Bio

Georgia Bio is the state’s trade association committed to driving growth in Georgia’s biosciences industry and its many sectors, including agri-biotech, food and nutrition, bio-based technologies and renewable chemicals, industrial and environmental biotech, medical devices and technologies, pharmaceuticals and consumer healthcare, diagnostics and research products, testing and research services, and clinical research. Georgia Bio members include bioscience companies, academic and research institutions, bioscience service providers, digital health companies, and related organizations. For more information, visit www.gabio.org or follow us on LinkedIn and Twitter @Georgia_Bio.